Biochemical pharmacology and therapeutic aspects of thrombolytic agents

Articulating the value of health research.

QJM : monthly journal of the Association of Physicians·2014

The Spanish toxic oil syndrome: Some explanations for the pathology and an appraisal of the similarities with other episodes of food adulteration.

Disasters·2010

The impact of genetics on medical education and training.

British medical bulletin·2000

Chemical derivatization of therapeutic proteins.

Trends in biotechnology·1993

Monitoring of streptokinase resistance titre in acute myocardial infarction patients up to 30 months after giving streptokinase or anistreplase and related studies to measure specific antistreptokinase IgG.

British heart journal·1992

Lack of influence of pretreatment antistreptokinase antibody on efficacy in a multicenter patency comparison of intravenous streptokinase and anistreplase in acute myocardial infarction.

American heart journal·1992

GPCR signaling from a primary cilium perspective.

Pharmacological reviews·2026

The promise of biased ligands in therapeutics.

Pharmacological reviews·2026

Kv7 channels as pharmacological targets for central nervous system diseases.

Pharmacological reviews·2026

Recombinant protein drug metabolism and pharmacokinetics.

Pharmacological reviews·2026

Application of human liver cell models in drug development and toxicity studies: The role of membrane transporters.

Pharmacological reviews·2026

The skeletal connectome: From molecular circuitry to systemic network medicine.

Pharmacological reviews·2026

Clinical efficacy of Radix Arnebiae oil in patients undergoing incision and drainage of perianal abscess and its effects on pyroptosis.

Frontiers in cellular and infection microbiology·2026

Repurposing Antipsychotic Agents in Oncology: Mechanistic Rationale, Emerging Evidence, and Therapeutic Potential.

Cancers·2026

Editorial: Clinical Guidelines and Real Practice of Antimicrobial Pharmacotherapy.

Antibiotics (Basel, Switzerland)·2026

Lerodalcibep-liga as an Injectable Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9)-Targeted Therapy for Patients With Hypercholesterolemia.

The Annals of pharmacotherapy·2026

Examining physicians' behaviors regarding buprenorphine prescribing for opioid use disorder.

Journal of opioid management·2026

Phospholipases D: An Update on Structure-Function Relationships.

Methods in molecular biology (Clifton, N.J.)·2026

Related Experiment Videos

Biochemical pharmacology and therapeutic aspects of thrombolytic agents

Related Concept Videos

Articulating the value of health research.

The Spanish toxic oil syndrome: Some explanations for the pathology and an appraisal of the similarities with other episodes of food adulteration.

The impact of genetics on medical education and training.

Chemical derivatization of therapeutic proteins.

Monitoring of streptokinase resistance titre in acute myocardial infarction patients up to 30 months after giving streptokinase or anistreplase and related studies to measure specific antistreptokinase IgG.

Lack of influence of pretreatment antistreptokinase antibody on efficacy in a multicenter patency comparison of intravenous streptokinase and anistreplase in acute myocardial infarction.

GPCR signaling from a primary cilium perspective.

The promise of biased ligands in therapeutics.

Kv7 channels as pharmacological targets for central nervous system diseases.

Recombinant protein drug metabolism and pharmacokinetics.

Application of human liver cell models in drug development and toxicity studies: The role of membrane transporters.

The skeletal connectome: From molecular circuitry to systemic network medicine.

Clinical efficacy of Radix Arnebiae oil in patients undergoing incision and drainage of perianal abscess and its effects on pyroptosis.

Repurposing Antipsychotic Agents in Oncology: Mechanistic Rationale, Emerging Evidence, and Therapeutic Potential.

Editorial: Clinical Guidelines and Real Practice of Antimicrobial Pharmacotherapy.

Lerodalcibep-liga as an Injectable Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9)-Targeted Therapy for Patients With Hypercholesterolemia.

Examining physicians' behaviors regarding buprenorphine prescribing for opioid use disorder.

Phospholipases D: An Update on Structure-Function Relationships.

Related Experiment Videos

Biochemical pharmacology and therapeutic aspects of thrombolytic agents

Related Concept Videos

Related Articles